World Vaccine Congress 2010

Article

The World Vaccine Congress Lyon is the premiere vaccine conference addressing all major vaccine markets.

The 12th annual World Vaccine Congress Lyon, organized by Terrapinn Ltd., opened on October 4, 2010, to provide solutions to today's biggest global challenges. Speakers, delegates, and exhibitors came from mainly European and North American regions to share their expertise, experience and services. The World Vaccine Congress Lyon is the premiere vaccine conference addressing all major vaccine markets, including influenza, HPV, pneumococcal, and meningococcal.

Sponsors and exhibitors present at the Congress include: Encorium, Millipore, Merck, GE Healthcare, Charles River labs, Eurocine, PAA Labs, SAFC, Fisher Clinical Services, Novozymes, Eurogentec, Vactia, Lonza, Luminex, ITS Innovation, AVIR Green Hills Biotech, Lipotek, Abd Serotec, Werum Software, Vibalogics, BioKinetic Europe and Accelovance.

Key themes for this year’s event include:

  • From R&D to S&E; a paradigm shift for vaccine R&D
  • Innovative vaccine differentiation and indication expansion
  • New vaccine franchise evolution
  • Penetrating emerging markets for revenue growth
  • Creative market-access strategies, market innovation and expansion
  • Capturing value and contributing to partnership success
  • Novel vaccine engineering, adjuvant development and antigen delivery advances
  • Accessing innovation: the increasing importance of externalisation
  • Advancing regulatory pathways and bridging the safety divide

To learn more about the 12th annual World Vaccine Congress Lyon and to download the conference brochure, click here.

A list of speakers who are scheduled to present at this year’s Congress is available here.

Recent Videos
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Signs and Symptoms of Connective Tissue Disease
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
© 2024 MJH Life Sciences

All rights reserved.